Myokardia Inc (OQ:MYOK)

Business Focus: Bio Therapeutic Drugs

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for MYOK within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 30th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 4/20 Mar 2/20 Gianakakos Anastasios Direct Ownership Common Stock S - Open market or private sale -22 $65.97
Mar 4/20 Mar 2/20 Gianakakos Anastasios Direct Ownership Common Stock S - Open market or private sale -1,800 $65.19
Mar 4/20 Mar 2/20 Gianakakos Anastasios Direct Ownership Common Stock S - Open market or private sale -2,070 $64.35
Mar 4/20 Mar 2/20 Gianakakos Anastasios Direct Ownership Common Stock S - Open market or private sale -1,108 $63.40
Feb 19/20 Feb 14/20 Ladd Cynthia J Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 10,034  
Feb 19/20 Feb 14/20 Ladd Cynthia J Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 31,079  
Feb 19/20 Feb 14/20 Gianakakos Anastasios Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 46,083  
Feb 19/20 Feb 14/20 Gianakakos Anastasios Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 142,733  
Feb 19/20 Feb 14/20 Bauer Jake Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 14,591  
Feb 19/20 Feb 14/20 Bauer Jake Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 45,193  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for MYOK within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 30th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 4/20 Mar 2/20 Gianakakos Anastasios Direct Ownership Common Stock S - Open market or private sale -22 $65.97
Mar 4/20 Mar 2/20 Gianakakos Anastasios Direct Ownership Common Stock S - Open market or private sale -1,800 $65.19
Mar 4/20 Mar 2/20 Gianakakos Anastasios Direct Ownership Common Stock S - Open market or private sale -2,070 $64.35
Mar 4/20 Mar 2/20 Gianakakos Anastasios Direct Ownership Common Stock S - Open market or private sale -1,108 $63.40
Mar 4/20 May 4/18 Gianakakos Anastasios Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -3,000  
Mar 4/20 May 4/18 Gianakakos Anastasios Direct Ownership Common Stock S - Open market or private sale -1,300 $47.95
Mar 4/20 May 4/18 Gianakakos Anastasios Direct Ownership Common Stock S - Open market or private sale -1,700 $47.27
Mar 4/20 May 4/18 Gianakakos Anastasios Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,000 $1.51
Feb 19/20 Feb 14/20 Ladd Cynthia J Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 10,034  
Feb 19/20 Feb 14/20 Ladd Cynthia J Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 31,079  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $MYOK